Joel Gore to Ticlopidine
This is a "connection" page, showing publications Joel Gore has written about Ticlopidine.
Connection Strength
0.345
-
Krimly A, Yan RT, Yan AT, DeYoung JP, Gallo R, Steg G, Eikelboom J, Gore JM, Fox KA, Fitchett D, Quantz MA, Goodman SG. Use of clopidogrel post-coronary artery bypass surgery in canadian patients with acute coronary syndromes. Can J Cardiol. 2011 Nov-Dec; 27(6):711-5.
Score: 0.094
-
Sibbald M, Yan AT, Huang W, Fox KA, Gore JM, Steg PG, Eagle KA, Brieger D, Montalescot G, Goodman SG. Association between smoking, outcomes, and early clopidogrel use in patients with acute coronary syndrome: insights from the Global Registry of Acute Coronary Events. Am Heart J. 2010 Nov; 160(5):855-61.
Score: 0.089
-
Rao RV, Goodman SG, Yan RT, Spencer FA, Fox KA, DeYoung JP, Rose B, Grondin FR, Gallo R, Gore JM, Yan AT. Temporal trends and patterns of early clopidogrel use across the spectrum of acute coronary syndromes. Am Heart J. 2009 Apr; 157(4):642-50.e1.
Score: 0.079
-
Lim MJ, Spencer FA, Gore JM, Dabbous OH, Agnelli G, Kline-Rogers EM, Dibenedetto D, Eagle KA, Mehta RH. Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry. Eur Heart J. 2005 Jun; 26(11):1063-9.
Score: 0.060
-
Awad HH, Zubaid M, Alsheikh-Ali AA, Al Suwaidi J, Anderson FA, Gore JM, Goldberg RJ. Comparison of characteristics, management practices, and outcomes of patients between the global registry and the gulf registry of acute coronary events. Am J Cardiol. 2011 Nov 01; 108(9):1252-8.
Score: 0.023